MIRM Stock Hits New High: Jumps 210% on Maralixibat Optimism
Meetings with the United States Food and Drug Administration are always key events for any pharmaceutical company, and it is especially so when it comes to a pre-New Drug Application (NDA). On Monday this week, ... [Read]